
Two commonly prescribed painkillers are set to be put under tighter controls in the United Kingdom after a number of …

The Anglo-Swedish pharma firm AstraZeneca has suspended investment into the United Kingdom, due to the uncertainty surrounding Brexit. The firm’s …

Current NICE guidance concerning the severity of the effects of antidepressant withdrawal is misleading doctors according to research published in …

The National Institute for Health Research (NIHR) has released a new whitepaper outlining the substantial benefits NHS High Throughput Centres …

GlaxoSmithKline has announced that it is to slash half of its workforce at its site in Ulverston, UK, as part …

Gilead’s CAR T therapy Yescarta is set to be made available on the NHS in England for adults with aggressive …

Male doctors in the United Kingdom earn 56% more than their female counterparts, according to a survey conducted by Medscape. …

A clinical trial looking into the safety and efficacy of the drug dutogliptin has been halted due to uncertainties surrounding …

In light of continued austerity gripping the NHS, it was uplifting to hear in July that the health service had …

Novo Nordisk has announced a wave of jobs cuts as part of a global restructure of its $1 billion R&D …

The British government has been accused of using Brexit to avoid implementing new EU legislation preventing powerful antibiotics from be …

Life expectancy has fallen for the first time in 35 years in Scotland, as data released by the National Records …

The Association of the British Pharmaceutical Industry (ABPI) has announced that it is forging a five year partnership with the …

A new report from Public Health England (PHE) has illuminated the primary health concerns in UK society today, revealing the …

Danish multinational Novo Nordisk has announced that they are increasing their stocks of insulin products to ensure that there are …